See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
UCB NPV (UCBJF.PK)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: UCBJF.PK
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Immunomedics Soars 49% on Mid-Stage Study of Lupus Drug
Aug 28, 2009
•
Small Cap Network
•
Comment!
FDA Calendar Updates: Transdel, Javelin, Jazz, Par Pharma
Jun 16, 2009
•
Mike Havrilla
•
2 Comments
Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
May 18, 2009
•
Mike Havrilla
•
1 Comment
Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test
May 15, 2009
•
Mike Havrilla
•
Comment!
Failure to Launch for Last Year's Big Pharma and Biotech Hopes
Feb 13, 2009
•
EP Vantage
•
Comment!
Biotech Day In Review: BioSimilar Cancer Drug Enters Trial
Mar 22, 2007
•
Centient Biotech Investor
•
Comment!
Biotech in Review: Genentech Extends Uses for Avastin and Xeloda
Feb 25, 2007
•
Centient Biotech Investor
•
1 Comment
Biotech Day in Review: ImClone Chooses to Go It Alone
Feb 7, 2007
•
Centient Biotech Investor
•
Comment!